Learn
More
Approved for Combination Use with solifenacin succinate*
*Marketed in the US as VESIcare®
Approved for Combination Use
For adults with overactive bladder symptoms of urgency, frequency and leakage, Myrbetriq® (mirabegron) is FDA-approved for use in combination with solifenacin succinate*. Ask your doctor if this combination treatment may be right for you.
*Marketed in the US as VESIcare®
Call for Savings: 1-855-984-6304
†Subject to eligibility. Restrictions may apply.

What is MYRBETRIQ?

MYRBETRIQ is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat the following symptoms due to a condition called overactive bladder:

  • Urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • Urgency: a strong need to urinate right away
  • Frequency: urinating often

It is not known if MYRBETRIQ, when used alone or with solifenacin succinate, is safe and effective in children.

How should I take MYRBETRIQ?

  • If your doctor prescribes MYRBETRIQ and solifenacin succinate together, you should take 1 MYRBETRIQ tablet and 1 solifenacin tablet at the same time, 1 time a day.
  • You should take MYRBETRIQ with water and swallow the tablet whole.
  • Do not chew, break, or crush the tablet.
  • You can take MYRBETRIQ with or without food.
  • You can take MYRBETRIQ and solifenacin succinate together with or without food.

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include:

  • dry mouth
  • urinary tract infection
  • constipation
  • fast heartbeat

USE OF MYRBETRIQ

Myrbetriq® (mirabegron) is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

IMPORTANT SAFETY INFORMATION FOR MYRBETRIQ

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®), or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include dry mouth, urinary tract infection, constipation, and fast heartbeat.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

USE OF VESICARE

VESIcare® (solifenacin succinate) is for overactive bladder with symptoms of urgency, frequency, and leakage.

IMPORTANT SAFETY INFORMATION FOR VESICARE

VESIcare is not for everyone. If you have certain stomach or glaucoma problems, or trouble emptying your bladder, do not take VESIcare. VESIcare may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat, or tongue, stop taking VESIcare and get emergency help. Tell your doctor right away if you have severe abdominal pain, or become constipated for three or more days. VESIcare may cause blurred vision, so use caution while driving or doing unsafe tasks. Common side effects are dry mouth, constipation, and indigestion.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for VESIcare® (solifenacin succinate).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® and VESIcare® are registered trademarks of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

Save up to $840 over one year! Subject to eligibility. Restrictions may apply.

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Frequently Asked Questions

What is overactive bladder (OAB)?

OAB is a medical condition involving urine storage in the body. OAB can happen when nerve signals between your bladder and brain tell your bladder to empty even when it isn't full. This may cause your bladder muscles to contract to pass urine before they should. These contractions cause the sudden, strong urgency to urinate or cause leakage.

Learn more

Isn't OAB something that happens to everyone when they get older?

OAB is not a normal part of aging. It is a medical condition that may be helped with appropriate treatment.

Learn more

What causes OAB symptoms?

OAB symptoms such as frequency, urgency, and urine leakage occur with uncontrolled contractions of the bladder muscle. Medical reasons for this can be unknown. Talk to your healthcare professional (HCP) about your OAB symptoms and what treatment option is appropriate for you.

Learn more

What can be done for OAB symptoms?

When a diagnosis of OAB is made, your healthcare professional (HCP) might suggest dietary and lifestyle changes and/or a prescription medicine. You can also sign up for the Momentum Program, a program that offers information about OAB management including practical tips, expert advice, and unique tools.

Learn more

Can I treat my OAB symptoms on my own?

OAB is a medical condition that requires proper diagnosis and treatment. Your healthcare professional (HCP) should determine the appropriate method of treatment for your OAB symptoms. Following that treatment program and sticking with it is your best course of action.

Learn more

What is Myrbetriq® (mirabegron)?

Myrbetriq is a prescription medicine approved by the FDA to treat OAB with symptoms of urgency, frequency and leakage in adults.

Learn more

Why might my healthcare professional decide that Myrbetriq is for me?

When Myrbetriq was studied in clinical trials, it was shown to be effective in treating symptoms of OAB within several weeks. Those patients taking Myrbetriq made fewer trips to the bathroom and had fewer leaks than those patients not taking Myrbetriq. Your results may vary.

Learn more

How does Myrbetriq work?

Myrbetriq is the first and only FDA‑approved treatment in its class. When taken as directed, Myrbetriq can help relax the smooth muscle that surrounds the bladder and may increase the bladder's ability to store urine.

Learn more

What are the possible side effects?

Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril and Mellaril‑S), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

The most common side effects include increased blood pressure, common cold symptoms, dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder. These are not all the possible side effects of Myrbetriq. Tell your doctor if you have any side effect that bothers you or that does not go away or if you have swelling of the face, lips, tongue, or throat, hives, skin rash or itching while taking Myrbetriq.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Learn more

Do I need to take Myrbetriq every day?

Yes. It is important that you take 1 Myrbetriq tablet 1 time a day as prescribed by your healthcare professional (HCP). Don't take it only when your symptoms are especially bothersome, or when you're about to have a big event or take a long car ride. Take it with water and swallow the tablet whole. Do not chew, break, or crush the tablet. You can take Myrbetriq with or without food. If you miss a dose, begin taking Myrbetriq again the next day. Do not take 2 doses of Myrbetriq the same day. If you take too much Myrbetriq, call your doctor or go to the nearest hospital emergency room right away. Don't expect your OAB symptoms to improve overnight. It may take several weeks to see results. Your results may vary.

Learn more

How quickly does Myrbetriq take to work?

It may take several weeks to see results. Don't expect your OAB symptoms to improve overnight. Your results may vary.

Learn more

Use of Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to VITALS®.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide